Skip to main content
NRIX
NASDAQ Life Sciences

Nurix Secures $700M Upfront from Roche in Global BTK Degrader Deal, Totaling Up To $2.3B

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$16.37
Mkt Cap
$1.514B
52W Low
$8.195
52W High
$22.5
52W Position info
100% above low
Off High info
27% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

NRIX sits 100% above its 52-week low of $8.195.

Summary

Nurix Therapeutics announced a global collaboration with Roche for its lead BTK degrader, bexobrutideg. The deal includes a substantial $700 million upfront payment and potential milestone payments up to $2.3 billion. This follows an earlier news announcement of the collaboration and precedes an 8-K filing confirming the details. The $700 million upfront payment is highly material, representing a significant portion of Nurix's market capitalization, and provides substantial non-dilutive funding. This partnership with a major pharmaceutical company like Roche significantly de-risks the development of bexobrutideg and validates the program's potential, especially after the company reported a widened net loss and decreased collaboration revenue in its last 10-Q. The agreement is subject to HSR and other antitrust clearances.

At the time of this announcement, NRIX was trading at $16.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $8.20 to $22.50. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

NRIX - Latest Insights

NRIX
Nov 03, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.03
Real-time Price: $12.89 info
Change: -$9.15 (-42%) info
Market Cap: $1.408B info
NRIX
Nov 03, 2026, 4:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $17.88
Real-time Price: $12.89 info
Change: -$5.00 (-28%) info
Market Cap: $1.408B info
NRIX
Oct 13, 2026, 6:21 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $12.89 info
Change: -$9.62 (-43%) info
Market Cap: $1.408B info
NRIX
Oct 13, 2026, 6:19 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $12.89 info
Change: -$9.62 (-43%) info
Market Cap: $1.408B info
NRIX
Oct 12, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $23.06
Real-time Price: $12.89 info
Change: -$10.18 (-44%) info
Market Cap: $1.408B info